Publications

2025

• The MAIIA EPO Purification Gel Kit, 7D3—An Alternative Purification Kit for Screening and Confirmation ProceduresSchwenke, D., Hempel, J., Keiler, A. M. & Voss, S., Aug 2025, In: Drug Testing and Analysis. 17, 8, p. 1196-1201, 6 p.Electronic (full-text) versionResearch output: Contribution to journal > Research article
• The histone modifier KAT2A presents a selective target in a subset of well-differentiated microsatellite-stable colorectal cancersKufrin, V., Seiler, A., Brilloff, S., Rothfuß, H., Küchler, S., Schäfer, S., Rahimian, E. & 8 others, Jul 2025, In: Cell death and differentiation. 32, 7, p. 1259-1272, 14 p., 8Electronic (full-text) versionResearch output: Contribution to journal > Research article
• Differentially Expressed MicroRNAs in Testes of Dominant and Subordinate Nile Tilapia Males and Identification of Oni-miR-499 as Regulator of amh Gene ExpressionPrause, R., Eckart, J., Skrobanek, J., Thönnes, M. & Pfennig, F., 8 Apr 2025, In: Sexual Development. 19, 1-6, p. 10–31, 22 p.Electronic (full-text) versionResearch output: Contribution to journal > Research article
• A quiescence-like/TGF-β1-specific CRISPRi screen reveals drug uptake transporters as secondary targets of kinase inhibitors in AMLRahimian, E., Koochak, M., Traikov, S., Schroeder, M., Brilloff, S., Schäfer, S., Kufrin, V. & 11 others, 28 Mar 2025, In: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy. 81, 17 p., 101242Electronic (full-text) versionResearch output: Contribution to journal > Research article
• LC-MS/MS quantification of bacterial and fungal signal peptides via direct injection: a case study of cross-kingdom communicationPohl, C., Schuster, L., Rau, C., Gutbier, U., Beil, S., Börnick, H., Ostermann, K. & 1 others, Mar 2025, In: Analytical and Bioanalytical Chemistry. 417, 8, p. 1677-1689, 13 p.Electronic (full-text) versionResearch output: Contribution to journal > Research article
• RevCAR-mediated T-cell response against PD-L1-expressing cells turns suppression into activationCrespo, E., Loureiro, L. R., Stammberger, A., Hoffmann, L., Berndt, N., Hoffmann, A., Dagostino, C. & 8 others, 9 Feb 2025, In: npj Precision Oncology. 9, 1, 42Electronic (full-text) versionResearch output: Contribution to journal > Research article
• Oligonucleotide therapeutics in sports? An antidoping perspectiveParr, M. K. & Keiler, A. M., Jan 2025, In: Archiv der Pharmazie : Arch Pham. 358, 1, e2400404Electronic (full-text) versionResearch output: Contribution to journal > Review article

2024

• Controlled interkingdom cell-cell communication between Saccharomyces cerevisiae and Bacillus subtilis using quorum-sensing peptidesVološen, T., Gutbier, U., Korn, R., Korp, J., Göttsche, T., Schuster, L., Pohl, C. & 3 others, 12 Dec 2024, In: Frontiers in microbiology. 15 (2024), 12 p., 1477298Electronic (full-text) versionResearch output: Contribution to journal > Research article
• Benchmarking whole exome sequencing in the German network for personalized medicineMenzel, M., Martis-Thiele, M., Goldschmid, H., Ott, A., Romanovsky, E., Siemanowski-Hrach, J., Seillier, L. & 105 others, Nov 2024, In: European journal of cancer. 211, 114306Electronic (full-text) versionResearch output: Contribution to journal > Research article
• Elimination profile of low-dose chlortalidone and its detection in hair for doping analysis-Implication for unintentional non-therapeutic exposureThieme, D., Weigel, K., Anielski, P., Krumbholz, A., Sporkert, F. & Keiler, A. M., Nov 2024, In: Drug testing and analysis. 16(2024), 11, p. 1378-1383, 6 p.Electronic (full-text) versionResearch output: Contribution to journal > Research article